Entheon Biomedical Corp. (CSE: ENBI, OTCQB: ENTBF) is pioneering a leading-edge addiction recovery solution. The company is focusing primarily on the powerful DMT molecule. Entheon exists to invert the addiction recovery ratio, turning the ‘untreatable case’ and ‘lost cause’ from the norm to the exception.

DMT:
DMT is a naturally occurring molecule that has been chemically synthesized for clinical use. Entheon is researching and developing DMT to address substance use disorders related to nicotine, alcohol, and more.

Further, Entheon has recently introduced its HaluGen test kit to the U.S. market. The test kit is a direct consumer genetic test kit. It looks for a variety of psychiatric risk factors, as well as metabolic factors that will indicate whether a person is more or less likely to have or develop psychiatric disorders

For more information: https://b-tv.com/entheon-biomedical-psychedelic-medicines-addiction-company-feature-ep-362/

Subscribe to receive more investment opportunities videos: http://bit.ly/Subscribe2BTV
Check out more videos:
BTV Business Television episodes: http://bit.ly/2UBerea
CEO Clips: http://bit.ly/2UTdumA
New Listing Alert: http://bit.ly/2W1o0ob

#DMT #Entheon #ENBI

source

A message from Love Heals The World:

– Hey Healers, please join us today in praying for the world. We’ve created the Let Us Pray category to highlight some of the challenges the world is facing and we believe that love has the power to heal those creating the challenges and those affected by them.

Please spread the love by supporting the link and platforms in the post and if you have a public prayer for this particular topic share it in the comments below. – #LHTW